293 related articles for article (PubMed ID: 9174799)
1. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
Grundy SM
Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
[No Abstract] [Full Text] [Related]
2. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
Malloy MJ; Kane JP
Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
[No Abstract] [Full Text] [Related]
3. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
[TBL] [Abstract][Full Text] [Related]
4. Statins in the prevention of coronary heart disease.
Williamson DR; Pharand C
Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives.
McKenna CJ; Sugrue DD
Ir Med J; 1995; 88(6):191. PubMed ID: 8575912
[No Abstract] [Full Text] [Related]
6. Lowering cholesterol in patients with coronary heart disease: are we ready yet?
Barrett-Connor E
Circulation; 1997 Dec; 96(12):4124-5. PubMed ID: 9416875
[No Abstract] [Full Text] [Related]
7. [Statin treatment in type 2 diabetes. Is it a must today?].
Faust M
MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
[No Abstract] [Full Text] [Related]
8. Cholesterol and coronary heart disease: screening and treatment.
Turner-Boutle M
Nurs Times; 1998 Apr 15-21; 94(15):46-7. PubMed ID: 9615661
[TBL] [Abstract][Full Text] [Related]
9. [Value of determining serum cholesterol levels in patients with coronary heart disease].
Stalenhoef AF
Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
[TBL] [Abstract][Full Text] [Related]
10. [When is lipid-lowering therapy appropriate for stroke?].
Terént A
Nord Med; 1997 Nov; 112(9):320-2, 338. PubMed ID: 9424603
[TBL] [Abstract][Full Text] [Related]
11. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
Mosca LJ
Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy of severe hypercholesterolemia.
Weizel A; Richter WO
Eur J Med Res; 1997 Jun; 2(6):265-9. PubMed ID: 9182654
[TBL] [Abstract][Full Text] [Related]
13. Statin therapy for prevention of coronary artery disease with average cholesterol levels.
Gambhir DS
Indian Heart J; 1999; 51(1):19-20, 105. PubMed ID: 10327772
[No Abstract] [Full Text] [Related]
14. National service framework for coronary heart disease. Target of lowering cholesterol by 30% needs to be justified.
Cracknell P
BMJ; 2000 Sep; 321(7261):634. PubMed ID: 11023319
[No Abstract] [Full Text] [Related]
15. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
16. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol lowering, sudden cardiac death and mortality.
de Lorgeril M; Salen P
Scand Cardiovasc J; 2008 Aug; 42(4):264-7. PubMed ID: 18615354
[TBL] [Abstract][Full Text] [Related]
18. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
Skałuba Z; Undas R
Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
[TBL] [Abstract][Full Text] [Related]
19. Therapy and clinical trials.
Dutta-Roy AK
Curr Opin Lipidol; 1999 Feb; 10(1):81-3. PubMed ID: 10095996
[No Abstract] [Full Text] [Related]
20. Optimal age for starting lipid lowering treatment. A 10 year risk of 30% should be used.
Simpson WG; Twomey P
BMJ; 2000 Sep; 321(7261):637; author reply 638. PubMed ID: 11023327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
